Molecular Genetics Thalassaemia Department


RESTORE - the Large-Scale Research Initiative for Advanced Therapies in Europe


We at the Cyprus Institute of Neurology & Genetics are part of the RESTORE community and through efforts of the Molecular Genetics Thalassaemia Department wholeheartedly support the aims of RESTORE – the Large-Scale Research Initiative that strives to propel Europe to the forefront in Advanced Therapies.

Shifting from treating symptoms to curing diseases and making Europe the world leader in Advanced Therapies is the aspiration of RESTORE, led by Charité. On 8th February, the European Commission (EC) backed that vision and announced that RESTORE will receive initial funding of EUR 1m and invited the consortium to fully develop their concept and to further expand the RESTORE community. Click here to find out more information on the successful funding of the preparatory phase of RESTORE. 

As a successful Large-Scale-Research Initiative RESTORE will eventually disburse up to EUR 1 billion over ten years from the EC to deliver a pipeline of transformative cures for the benefit of struggling patients. RESTORE will promote groundbreaking research, nurture innovative companies and engage the public; its concept is supported by a broad international and interdisciplinary community of stakeholders, who united behind the mission to make patient-centered value at high ethical and quality standards a reality.

RESTORE will organize its official kick-off event on 6–7 May 2019 in Berlin, Germany. If you want to support RESTORE and be kept abreast of developments, click the link below. 


Related Articles